Wang Hong, Ullah Zakir, Gazit Eran, Brozgol Marina, Tan Tian, Hausdorff Jeffrey M, Shull Peter B, Ponger Penina
IEEE J Biomed Health Inform. 2025 Jan;29(1):81-94. doi: 10.1109/JBHI.2024.3470310. Epub 2025 Jan 7.
Step width is vital for gait stability, postural balance control, and fall risk reduction. However, estimating step width typically requires either fixed cameras or a full kinematic body suit of wearable inertial measurement units (IMUs), both of which are often too expensive and time-consuming for clinical application. We thus propose a novel data-augmented deep learning model for estimating step width in individuals with and without neurodegenerative disease using a minimal set of wearable IMUs. Twelve patients with neurodegenerative, clinically diagnosed Spinocerebellar ataxia type 3 (SCA3) performed over ground walking trials, and seventeen healthy individuals performed treadmill walking trials at various speeds and gait modifications while wearing IMUs on each shank and the pelvis. Results demonstrated step width mean absolute errors of 3.3 0.7 cm and 2.9 0.5 cm for the neurodegenerative and healthy groups, respectively, which were below the minimal clinically important difference of 6.0 cm. Step width variability mean absolute errors were 1.5 cm and 0.8 cm for neurodegenerative and healthy groups, respectively. Data augmentation significantly improved accuracy performance in the neurodegenerative group, likely because they exhibited larger variations in walking kinematics as compared with healthy subjects. These results could enable clinically meaningful and accurate portable step width monitoring for individuals with and without neurodegenerative disease, potentially enhancing rehabilitative training, assessment, and dynamic balance control in clinical and real-life settings.
步幅宽度对于步态稳定性、姿势平衡控制和降低跌倒风险至关重要。然而,估计步幅宽度通常需要固定摄像头或一套完整的可穿戴惯性测量单元(IMU)组成的运动服,这两者对于临床应用来说往往都过于昂贵且耗时。因此,我们提出了一种新颖的数据增强深度学习模型,用于使用最少的可穿戴IMU来估计患有和未患有神经退行性疾病的个体的步幅宽度。12名临床诊断为3型脊髓小脑共济失调(SCA3)的神经退行性疾病患者进行了地面行走试验,17名健康个体在每条小腿和骨盆上佩戴IMU的同时,以不同速度和步态变化进行了跑步机行走试验。结果表明,神经退行性疾病组和健康组的步幅宽度平均绝对误差分别为3.3±0.7厘米和2.9±0.5厘米,均低于6.0厘米的最小临床重要差异。神经退行性疾病组和健康组的步幅宽度变异性平均绝对误差分别为1.5厘米和0.8厘米。数据增强显著提高了神经退行性疾病组的准确性表现,可能是因为与健康受试者相比,他们在行走运动学上表现出更大的变化。这些结果能够为患有和未患有神经退行性疾病的个体实现具有临床意义且准确的便携式步幅宽度监测,有可能在临床和现实生活环境中加强康复训练、评估和动态平衡控制。